Status:
UNKNOWN
Consuming of Opuntia Among Women With Fibromyalgia
Lead Sponsor:
Soroka University Medical Center
Collaborating Sponsors:
Ben-Gurion University of the Negev
Conditions:
Fibromyalgia (FM)
Eligibility:
FEMALE
18-120 years
Phase:
NA
Brief Summary
To examine whether the addition of tzabar fruit twice a day to a routine daily nutrition regime will: A- Reduce symptoms of fatigue, pain and depression in FM patients B. Have positive influence on ...
Detailed Description
Project description Fibromyalgia (FM) is a chronic and idiopathic syndrome, characterized by a general distributed pain, more prevalent in women. Alongside with musculoskeletal pain, symptoms of fatig...
Eligibility Criteria
Inclusion
- women diagnosed with FM
- Age over 18
- Fluent in Hebrew
Exclusion
- sensitivity to tzabar/exotic fruits
- Suffer from digestive issues, such as irritable bowel syndrome
- Participating in another interventional study
- Removal criteria
- \- Participants who do not complete the study follow-up period.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2024
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT05230602
Start Date
June 1 2022
End Date
June 1 2024
Last Update
December 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Soroka Medical Center
Beersheba, Southern District, Israel, 151